Loading company…
PANACRO provides pharmaceutical research, clinical trial, and regulatory filing services.
Founded in 2004 and based in Beijing, PANACRO provides clinical research and regulatory filing services for chemical and biological drugs and vaccines. Its work includes Phase I-IV trials, data management, and statistical analysis. In December 2023, it raised approximately CNY 100 million in Series B1 funding to support international expansion, digital services, and growth in North America and Southeast Asia.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in